Hamad A - Search Results

1

Oncologic Outcomes After Robotic Pancreatic Resections Are Not Inferior to Open Surgery.

Girgis MD, Zenati MS, King JC, Hamad A, Zureikat AH, Zeh HJ, Hogg ME. Girgis MD, et al. Among authors: hamad a. Ann Surg. 2021 Sep 1;274(3):e262-e268. doi: 10.1097/SLA.0000000000003615. Ann Surg. 2021. PMID: 31663967

2

Analysis of Perioperative Chemotherapy in Resected Pancreatic Cancer: Identifying the Number and Sequence of Chemotherapy Cycles Needed to Optimize Survival.

Epelboym I, Zenati MS, Hamad A, Steve J, Lee KK, Bahary N, Hogg ME, Zeh HJ, Zureikat AH. Epelboym I, et al. Among authors: hamad a. Ann Surg Oncol. 2017 Sep;24(9):2744-2751. doi: 10.1245/s10434-017-5975-3. Epub 2017 Jul 5. Ann Surg Oncol. 2017. PMID: 28681155

3

Neoadjuvant Treatment With Trastuzumab and FOLFOX Induces a Complete Pathologic Response in a Metastatic ERBB2 (HER2)-Amplified Duodenal Cancer.

Hamad A, Singhi AD, Bahary N, McGrath K, Amarin R, Zeh HJ, Zureikat AH. Hamad A, et al. J Natl Compr Canc Netw. 2017 Aug;15(8):983-988. doi: 10.6004/jnccn.2017.0140. J Natl Compr Canc Netw. 2017. PMID: 28784859

4

Robotic central pancreatectomy.

Hamad A, Novak S, Hogg ME. Hamad A, et al. J Vis Surg. 2017 Jul 26;3:94. doi: 10.21037/jovs.2017.05.13. eCollection 2017. J Vis Surg. 2017. PMID: 29078656 Free PMC article. Review.

5

Resident attitudes and compliance towards robotic surgical training.

Tam V, Lutfi W, Novak S, Hamad A, Lee KK, Zureikat AH, Zeh HJ 3rd, Hogg ME. Tam V, et al. Among authors: hamad a. Am J Surg. 2018 Feb;215(2):282-287. doi: 10.1016/j.amjsurg.2017.08.051. Epub 2017 Nov 14. Am J Surg. 2018. PMID: 29174164

6

Safety and feasibility of the robotic platform in the management of surgical sequelae of chronic pancreatitis.

Hamad A, Zenati MS, Nguyen TK, Hogg ME, Zeh HJ 3rd, Zureikat AH. Hamad A, et al. Surg Endosc. 2018 Feb;32(2):1056-1065. doi: 10.1007/s00464-017-6010-2. Epub 2017 Dec 22. Surg Endosc. 2018. PMID: 29273874

7

Robotic pancreatoduodenectomy at an experienced institution is not associated with an increased risk of post-pancreatic hemorrhage.

Magge D, Zenati M, Lutfi W, Hamad A, Zureikat AH, Zeh HJ, Hogg ME. Magge D, et al. Among authors: hamad a. HPB (Oxford). 2018 May;20(5):448-455. doi: 10.1016/j.hpb.2017.11.005. Epub 2018 Feb 1. HPB (Oxford). 2018. PMID: 29366816 Free article.

8

FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel for Neoadjuvant Treatment of Resectable and Borderline Resectable Pancreatic Head Adenocarcinoma.

Dhir M, Zenati MS, Hamad A, Singhi AD, Bahary N, Hogg ME, Zeh HJ 3rd, Zureikat AH. Dhir M, et al. Among authors: hamad a. Ann Surg Oncol. 2018 Jul;25(7):1896-1903. doi: 10.1245/s10434-018-6512-8. Epub 2018 May 14. Ann Surg Oncol. 2018. PMID: 29761331 Clinical Trial.

9

CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over Time.

Rieser CJ, Zenati M, Hamad A, Al Abbas AI, Bahary N, Zureikat AH, Zeh HJ 3rd, Hogg ME. Rieser CJ, et al. Among authors: hamad a. Ann Surg Oncol. 2018 Nov;25(12):3483-3491. doi: 10.1245/s10434-018-6521-7. Epub 2018 May 21. Ann Surg Oncol. 2018. PMID: 29786131

10

Can post-hoc video review of robotic pancreaticoduodenectomy predict portal/superior mesenteric vein margin status in pancreatic adenocarcinoma?

Jung JP, Zenati MS, Hamad A, Hogg ME, Simmons RL, Zureikat AH, Zeh HJ, Boone BA. Jung JP, et al. Among authors: hamad a. HPB (Oxford). 2019 Jun;21(6):679-686. doi: 10.1016/j.hpb.2018.10.012. Epub 2018 Nov 28. HPB (Oxford). 2019. PMID: 30501987 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

760 results

Search Page

Filters